What Caught Our Attention: Last year, a journal retracted a paper about a child who developed a rare complication related to the inherited disorder Gaucher Disease, after realizing it had inadvertently identified the child. It wasn’t an immediately obvious mistake — the authors listed the drugs the patient was taking, and in the case of one drug, there was only one child in the world taking it. For anyone in the know, that would make the child’s identity clear.
So retracting the paper makes sense — but publishing a retraction notice that spells out the issue in detail, including the name of the drug and the fact the patient was the only pediatric recipient, did not. So last month, the Journal of Pediatric Hematology/Oncology corrected the retraction notice, removing the name of the drug. (Phew.)
An anatomy journal has banned a researcher from submitting papers for three years after determining one of his recently published papers suffered from “serious ethical” issues.
According to Jae Seung Kang, associate editor at the journal Anatomy and Cell Biology (ACB), the paper’s sole author—Jae Chul Lee—falsified both his affiliation and approval for conducting animal experiments in the paper, published online in March.
Journals are raising ethical concerns about the research of a doctor who offers controversial embryonic stem cell treatments.
Two journals have issued expressions of concern for three papers by Geeta Shroff, who was the subject of a 2012 CNN investigative documentary. All cite ethical concerns; one mentions the potential link between the procedure the authors describe and a risk of forming teratomas, a type of tumor. Shroff has objected to all three notices.
Psychiatry journals have retracted two papers evaluating a schizophrenia drug after a university in Japan flagged issues, such as a lack of written informed consent.
The papers—published in Human Psychopharmacology: Clinical & Experimental in 2012 and Psychiatry and Clinical Neurosciences in 2014—examined the safety and effectiveness of an antipsychotic drug in patients with schizophrenia.
According to the retraction notice in Psychiatry and Clinical Neurosciences, the ethics committee at St. Marianna University School of Medicine in Kawasaki found that “the trial included subjects who did not satisfy inclusion criteria.” For instance, not all patients provided written informed consent. But the university found no evidence for data falsification or fabrication.
A food science journal has retracted a paper over “a breach of reviewer confidentiality,” after editors learned it contained text from an unpublished manuscript — which one of the authors appears to have reviewed for another journal.
The publisher and editors-in-chief of the Journal of Food Process Engineering became aware of the breach when the author of the unpublished manuscript lodged a complaint that his paper, under review at another journal, had been plagiarized by the now retracted paper.
We’re hazy on a few details in this case. Although the journal editor told us the “main author” of the retracted paper reviewed the original manuscript for another journal, the corresponding author of the retracted paper said he was not to blame. (More on that below.)
A researcher in South Korea has retracted a 2015 paper after telling the journal he falsified the institutional approval required to conduct the animal experiments.
In the article, the author explicitly says that the Animal Experiment Review Board of a university based in Seoul, South Korea approved the experiments, but according to the journal, “the author did not receive an approval by the board and he used a false approval number.”
A psychoanalyst has retracted an award-winning 2016 paper over concerns that it contained “sensitive” patient information.
On July 15, Judith L. Mitrani, a psychoanalyst based in California, published an article that included “sensitive clinical material” about a patient. Although we do not know what prompted the concerns, on November 21, Mitrani, in agreement with the journal’s editor-in-chief and publisher, retracted the article. The author and editor told us the retraction was meant to prevent non-experts from accessing the paper and to stop other non-Wiley sites from posting it.
The article was published after it had won the journal’s essay contest in 2015.